EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Design of Putative Dual-Target Opioid-Dopaminergic Casomorphin–Ranatensin Hybrid Peptides: Computational Modeling and Preliminary Antiproliferative Evaluation

Krystian Małek, Adrian Górski, Łukasz Szeleszczuk iD, Anna K Laskowska, Zuzanna Markowska, Sebastian Granica iD, Anna Pogorzelska iD, Piotr Koch, Natalia Pielaszkiewicz, Jagoda Michniewicz, Wojciech Kamysz iD, Małgorzata Milczarek iD und 2 weitere

Molecules · 2026

DOI: 10.3390/molecules31183221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Krystian Małek und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Research, National Medicines Institute, 00-725 Warsaw, Poland. Hauptthemen laut MEDLINE: Receptors, Opioid, mu, Antineoplastic Agents, Peptides, Receptors, Dopamine D2. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in oncology, cancer remains a leading cause of mortality worldwide, and both μ-opioid receptor (MOR) and dopamine D2 receptor (D2R) signaling have been implicated in the regulation of tumor proliferation, survival, and progression, positioning them as attractive targets for multifunctional anticancer strategies. In the present study, a series of novel casomorphin–ranatensin hybrid peptides were designed, synthesized, and evaluated as putative dual-target anticancer agents combining MOR and D2R pharmacophores. Among the evaluated analogues, KAZO_5.2 and KAZO_7.2 reduced viability of HCT116 colorectal cancer cells in a dose- and time-dependent manner, with a modest selectivity ratio compared to non-tumorigenic MCF 10A cells. Both compounds showed favorable docking scores toward MOR and D2R, while single 100 ns molecular dynamics trajectories showed that the peptides remained associated with their respective receptor models over the simulated timescale. Partial reversal of the viability-reducing effect by naloxone suggested involvement of opioid-sensitive pathways, while only low baseline MOR expression was detected in HCT116 cells under our experimental conditions, consistent with a possible contribution of additional receptor-mediated mechanisms to the observed activity. Neither compound induced pronounced apoptosis or cell cycle arrest, suggesting cytostatic rather than cytotoxic effects. Both peptides exhibited negligible hemolytic activity and high proteolytic stability in human plasma, with intact peptides remaining predominant after 24 h of incubation at 37 °C. These findings identify casomorphin–ranatensin hybrids as a promising scaffold for dual-target anticancer peptide development, warranting further structural optimization and mechanistic investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Opioid, muAntineoplastic AgentsPeptidesReceptors, Dopamine D2Drug DesignHumansCell ProliferationMolecular Dynamics SimulationHCT116 CellsMolecular Docking SimulationCell SurvivalCell Line, Tumor

Stichwörter der Autor:innen

antiproliferative activitycasomorphinshybrid peptidesmolecular dockingmolecular dynamics

Substanzen

Receptors, Opioid, muAntineoplastic AgentsPeptidesReceptors, Dopamine D2

Autor:innen und Institutionen

  • Department of Biomedical Research, National Medicines Institute, 00-725 Warsaw, Poland.
  • Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk, 80-416 Gdansk, Poland.
  • Department of Organic and Physical Chemistry, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department of Pharmaceutical Microbiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Department of Pharmaceutical Biology, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Maria Sklodowska-Curie Medical Academy in Warsaw, 03-411 Warsaw, Poland.

ORCID-Profile: Łukasz Szeleszczuk, Sebastian Granica, Anna Pogorzelska, Wojciech Kamysz, Małgorzata Milczarek, Karol Sikora, Patrycja Kleczkowska

Förderung

  • Ministry of Science and Higher Education

Zitieren

APA

Małek, K., Górski, A., Szeleszczuk, Ł., Laskowska, A. K., Markowska, Z., Granica, S., Pogorzelska, A., Koch, P., Pielaszkiewicz, N., Michniewicz, J., Kamysz, W., Milczarek, M., Sikora, K., & Kleczkowska, P. (2026). Rational Design of Putative Dual-Target Opioid-Dopaminergic Casomorphin–Ranatensin Hybrid Peptides: Computational Modeling and Preliminary Antiproliferative Evaluation. Molecules. https://doi.org/10.3390/molecules31183221

Vancouver

Małek K, Górski A, Szeleszczuk Ł, Laskowska AK, Markowska Z, Granica S, et al. Rational Design of Putative Dual-Target Opioid-Dopaminergic Casomorphin–Ranatensin Hybrid Peptides: Computational Modeling and Preliminary Antiproliferative Evaluation. Molecules. 2026. doi:10.3390/molecules31183221

BibTeX
@article{Maek2026,
  author = {Małek, Krystian and Górski, Adrian and Szeleszczuk, Łukasz and Laskowska, Anna K and Markowska, Zuzanna and Granica, Sebastian and Pogorzelska, Anna and Koch, Piotr and Pielaszkiewicz, Natalia and Michniewicz, Jagoda and Kamysz, Wojciech and Milczarek, Małgorzata and Sikora, Karol and Kleczkowska, Patrycja},
  title = {Rational Design of Putative Dual-Target Opioid-Dopaminergic Casomorphin–Ranatensin Hybrid Peptides: Computational Modeling and Preliminary Antiproliferative Evaluation},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31183221}
}
Kostenlos starten →